The upgrade to 5G was supposed to bring a paradise of speedy wireless. But a chaotic process under the Trump administration, allowed to fester by the Biden administration, turned it into an epic disaster. The problems haven’t been solved.

He was in police custody at the time of the murders, but a dubious confession led to his wrongful conviction while Chicago police and prosecutors turned a blind eye to inconvenient facts that eventually exonerated him.

A federal investigator emailed Nevada officials, notifying them that he would subpoena documents related to Northshore Clinical Labs’ operations in the state.

The Illinois attorney general’s office said it is trying to determine if a suburban Chicago school district violated students’ civil rights when police ticketed them for minor misbehavior.

The U.S. government promised Native tribes in the Pacific Northwest that they could keep fishing as they’d always done. But instead of preserving wild salmon, it propped up a failing system of hatcheries. Now, that system is falling apart.

How obscure retiree Jay Stone played a crucial, if little-known, role in making Wisconsin a hotbed of conspiracy theories that Democrats stole the state’s 10 electoral votes from Donald Trump.

The Russia-linked ransomware gang Conti avoided the sanctions that hit Russian banks and businesses after the invasion of Ukraine, spotlighting the difficulty of reining in cybercriminals. Meanwhile, confused victims face uncertainty.

A whistleblower says a plan to build a grain elevator on an old plantation would disrupt important historic sites, including possibly unmarked graves of enslaved people, and that her cultural resource management firm tried to bury her findings.

Calvert City, Kentucky, has long had what people in other toxic hot spots have been begging for: monitors to prove they’re being exposed to toxic industrial air pollution. Regulators have years of evidence, but the poison in the air is only growing.

A trove of documents published as part of a legal settlement offers an unvarnished look inside the financial relationships between pharmaceutical companies and the medical community — from the perspective of drug companies themselves.